Journalism begins where hype ends

,,

We’re creating alien beings. I’m willing to be selfish and choose humans"

—Geoffrey Hinton, 'Godfather of AI'

OpenAI Acquires Orchestra Bio to Advance AI Drug Development with GPT-Rosalind

OpenAI’s AI-powered life sciences research aims to accelerate drug discovery and development through advanced scientific tools and AI-driven workflows.

OpenAI has acquired four-year-old Orchestra Bio, a startup building AI agents to help pharmaceutical companies manage drug development. The company plans to bring Orchestra Bio’s team and technology together with Rosalind, its AI models and tools for life sciences research. “Our goal is to help scientists make discoveries and manage the work needed to turn… Continue reading OpenAI Acquires Orchestra Bio to Advance AI Drug Development with GPT-Rosalind

AI Meets Big Pharma: Isomorphic Labs Raises $2.1 Billion for AI Drug Discovery

Isomorphic Labs, founded in 2021 by DeepMind chief Demis Hassabis, has raised $2.1 billion in Series B funding to scale its AI-driven drug discovery platform.

Demis Hassabis’s AI drug discovery startup Isomorphic Labs has raised $2.1 billion in a Thrive Capital-led Series B, joined by Alphabet, GV, MGX, Temasek, CapitalG and the UK Sovereign AI Fund.